| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/24/2004 | US20040120986 acidic beverages and oral healthcare compositions; use of calcium in such compositions to alleviate or prevent the tooth damage associated with the consumption of acid |
| 06/24/2004 | US20040120985 wherein the phosphatidyl serine is present in an amount of from 200 to 300 mg |
| 06/24/2004 | US20040120984 Compositions comprising dietary fat complexer and methods for their use |
| 06/24/2004 | US20040120983 Nutritional supplement |
| 06/24/2004 | US20040120977 Anti-inflammatory coatings for implantable medical devices and devices containing said coatings |
| 06/24/2004 | US20040120967 Use of L-carnitine for the treatment of cataract of non diabetic origin due to altered chaperone proteins by stabilizing the protein activity |
| 06/24/2004 | US20040120952 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 06/24/2004 | US20040120940 Placental alkaline phosphatase to control diabetes |
| 06/24/2004 | US20040120926 Reactive oxygen metabolite inhibitors for use in compositions and methods of treatment |
| 06/24/2004 | US20040120922 Method for promoting bone formation |
| 06/24/2004 | US20040120904 Delivery system for functional compounds |
| 06/24/2004 | US20040120896 Buccal aerosol sprays or capsules using polar and non-polar solvent which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect |
| 06/24/2004 | US20040120895 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 06/24/2004 | US20040118407 Device for artificial respiration |
| 06/24/2004 | US20040118354 Apparatus and method to feed hummingbirds |
| 06/24/2004 | DE69233189T2 Heteroarylpiperidine-pyrrolidine und piperazine und ihre anwendung als antipsychotisches und analgetisches mittel Heteroarylpiperidines-pyrrolidine and piperazine and its application as an antipsychotic and analgesic medium |
| 06/24/2004 | DE20220885U1 Kristallines und amorphes Mupirocin-Calcium Crystalline and amorphous mupirocin calcium |
| 06/24/2004 | DE10354940A1 Mittel zur buccodentalen Hygiene beim Menschen und in der Tierheilkunde mit Melatonin als aktivem Bestandteil Means for buccodentalen hygiene in humans and in animal medicine with melatonin as an active ingredient |
| 06/24/2004 | DE10259014A1 Antioxidans-Kombinationen mit6,7-disubstituierten 2,2-Dialkylchromanen oder-chromenen Antioxidant combinations mit6,7-disubstituted 2,2-Dialkylchromanen or-chromenes |
| 06/24/2004 | DE10258677A1 Combined use of antisense oligonucleotides for treating cancer, directed against the Polo-like kinase 1 and B cell leukemia/lymphoma 2 genes, having a synergistic effect |
| 06/24/2004 | DE10258239A1 Formulation used for treating non-chronic alcoholic intoxication, contains alpha-lipoic acid for scavenging free radicals and activating alcohol metabolizing enzymes |
| 06/24/2004 | DE10256976A1 Use of specific hydroxamic acids for inhibition of methionine aminopeptidase, useful for treatment of bacterial or fungal infections, or cancers and other diseases associated with angiogenesis |
| 06/24/2004 | DE10256881A1 Neue topische Verwendung von Bis-Arylimidazo[1,2-a]thiolanderivaten New topical use of bis-Arylimidazo [1,2-a] thiolanderivaten |
| 06/24/2004 | DE10256775A1 Preparation of film forming composition for transmucosal delivery of nicotine used for treating tobacco addiction, includes converting nicotine free base to its salt with acid and/or incorporation of nicotine as salt |
| 06/24/2004 | DE10252957A1 Sorbinsäure und/oder deren Salze als Antiinfektionsmittel gegen Kokzidien-Infektionen bei Tieren Sorbic acid and / or salts thereof as anti-infective agents against coccidial infections in animals |
| 06/24/2004 | CA2548608A1 Anhydrous crystalline form of valacyclovir hydrochloride |
| 06/24/2004 | CA2511763A1 Methods for treating diabetes |
| 06/24/2004 | CA2510610A1 Microtubule stabilisers for treating stenosis in stents |
| 06/24/2004 | CA2509599A1 Novel semisynthetic macrolide antibiotics of the azalide series |
| 06/24/2004 | CA2509142A1 Combination for the treatment of adhd |
| 06/24/2004 | CA2508990A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 06/24/2004 | CA2508796A1 Topical anti-infective formulations |
| 06/24/2004 | CA2508786A1 Methods for inhibiting cancer and scar formation |
| 06/24/2004 | CA2508766A1 Modification of cyclooxygenase and lipoxygenase activity with asteridae extracts and optionally boswellic acid |
| 06/24/2004 | CA2508762A1 Methods and compositions for treatment of otitis media |
| 06/24/2004 | CA2508722A1 Controlled-release of an active substance into a high fat environment |
| 06/24/2004 | CA2508681A1 Quinoline compounds for use in mch receptor related disorders |
| 06/24/2004 | CA2508663A1 Labeled macrophage scavenger receptor antagonists for imaging cardiovascular diseases |
| 06/24/2004 | CA2508656A1 Antiviral nucleoside derivatives |
| 06/24/2004 | CA2508623A1 Benzomorpholine derivatives |
| 06/24/2004 | CA2508619A1 Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof |
| 06/24/2004 | CA2508601A1 Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k |
| 06/24/2004 | CA2508596A1 A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis |
| 06/24/2004 | CA2508441A1 Propofol-containing fat emulsions |
| 06/24/2004 | CA2508170A1 Pyrazine-based tubulin inhibitors |
| 06/24/2004 | CA2508166A1 Compositions and methods related to lipid:emodin formulations |
| 06/24/2004 | CA2508004A1 Treatment of diseases with combinations of alpha 7 nicotinic acetylcholine receptor agonists and other compounds |
| 06/24/2004 | CA2507987A1 A vegetable composition having blood enhancing properties |
| 06/24/2004 | CA2507918A1 Use of spongosine (2-methoxyadenosein) for the treatment of pain, in particular hyperalgesia |
| 06/24/2004 | CA2507581A1 Protection of stem cells from cytotoxic agents by modulation of .beta.-catenin signaling pathways |
| 06/24/2004 | CA2507540A1 Method of reducing toxicity of anticancer agents |
| 06/24/2004 | CA2507137A1 Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents |
| 06/24/2004 | CA2507042A1 Tablet comprising efletirizine and pseudoephedrine |
| 06/24/2004 | CA2506529A1 Crystalline fumarate salts of 1-azabicyclo[2.2.2]oct substituted furo[2,3-c]pyridinyl carboxamide and compositions and preparations thereof |
| 06/24/2004 | CA2506432A1 Methods for selectively inhibiting janus tyrosine kinase 3 (jak3) |
| 06/24/2004 | CA2505975A1 Ultrasound contrast using halogenated xanthenes |
| 06/24/2004 | CA2505771A1 Combination of an dpp-iv inhibitor and a ppar-alpha compound |
| 06/24/2004 | CA2505608A1 Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 06/24/2004 | CA2505407A1 Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid |
| 06/24/2004 | CA2505335A1 Method of treating movement disorders using barbituric acid derivatives |
| 06/24/2004 | CA2505333A1 Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 06/24/2004 | CA2502625A1 Dioxolane thymine and combinations for use against resistant strains of hiv |
| 06/23/2004 | EP1431304A2 Beta - L-2'-Deoxy-Nucleosides for the treatment of Hepatitis B |
| 06/23/2004 | EP1431294A1 Vascular wall-selective acat inhibitor |
| 06/23/2004 | EP1431293A1 Water-soluble phenylpyridazine derivatives and drugs containing the same |
| 06/23/2004 | EP1431291A1 1-Aryl-4-cyano-3-cyclopropylpyrazole derivatives as ectoparasiticidal agents |
| 06/23/2004 | EP1431286A2 Prodigiosin derivatives for treating cancer or viral diseases |
| 06/23/2004 | EP1431285A1 Reverse hydroxamic acid derivatives |
| 06/23/2004 | EP1431284A1 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant |
| 06/23/2004 | EP1431280A1 Aryl sulfamate derivatives |
| 06/23/2004 | EP1430934A1 Product inhibiting transduction of G heterotrimeric protein signals combined with another anti-cancer agent for therapeutic use in cancer treatment |
| 06/23/2004 | EP1430933A2 Cosmetic and pharmaceutical compositions comprising steroid sulfatase inhibitors and their use for the reduction of hair loss |
| 06/23/2004 | EP1430917A1 Compositions and medical devices utilizing bioabsorbable polymeric waxes |
| 06/23/2004 | EP1430903A1 Use of proteasome inhibitors for the treatment of viral infections |
| 06/23/2004 | EP1430902A1 Pharmaceutical composition of interferon gamma with molecular diagnostics for the improved treatment of asthma bronchiale |
| 06/23/2004 | EP1430898A1 Receptor antagonist |
| 06/23/2004 | EP1430897A2 Opioid formulations having extended controlled release |
| 06/23/2004 | EP1430896A1 NICOTINE−CONTAINING FILM PREPARATION |
| 06/23/2004 | EP1430895A1 Novel substituted benzimidazole dosage forms and method of using same |
| 06/23/2004 | EP1430894A1 Lymphocytic activation inhibitor and remedial agent for autoimmune disease |
| 06/23/2004 | EP1430893A1 Stable gabapentin containing more than 20 ppm of chloride ion |
| 06/23/2004 | EP1430892A1 Aqueous ecabet sodium solution preparation |
| 06/23/2004 | EP1430891A1 Oil-acid-emulsion for the treatment of joint diseases and for the stimulation of blood-circulation |
| 06/23/2004 | EP1430890A1 Thrombus/thrombogenesis inhibitors |
| 06/23/2004 | EP1430887A1 Powder for inhalation containing Tiotropium |
| 06/23/2004 | EP1430882A2 Combinations of antioxidants containing 6,7-disubstituted 2,2-dialkylchromanes or -chromenes |
| 06/23/2004 | EP1430783A1 Oil/fat composition |
| 06/23/2004 | EP1430306A2 Method for predicting the sensitivity to chemotherapy |
| 06/23/2004 | EP1430157A2 RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS (HCV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 06/23/2004 | EP1430152A2 Gene and protein relating to hepatocellular carcinoma |
| 06/23/2004 | EP1430132A2 Methods of using 33751, a human potassium channel family member |
| 06/23/2004 | EP1430125A2 Sperm-specific cation channel, and uses therefor |
| 06/23/2004 | EP1430124A2 Artificial ubiquitous chromatin opening elements (ucoe) |
| 06/23/2004 | EP1430120A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 06/23/2004 | EP1430114A2 Prolactin induced increase in neural stem cell numbers and therapeutical use thereof |
| 06/23/2004 | EP1430074A1 Aminoglycoside lipid derivatives for transfection |
| 06/23/2004 | EP1430068A1 6-o-carbamate-11,12-lacto-ketolide antimicrobials |
| 06/23/2004 | EP1430060A2 7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors. |
| 06/23/2004 | EP1430059A1 Pharmaceutically acceptable salts of 20(s)-camptothecins |
| 06/23/2004 | EP1430058A1 Sodium salt of an hiv integrase inhibitor |